特发性炎性肌病:间质性肺病的CT特征及其与肌炎特异性自身抗体的关联
该研究纳入2003—2019年257例特发性炎性肌病患者,其中94例(36.6%)合并间质性肺病,87例(93%)为肌炎特异性自身抗体阳性。两名胸部放射科医师回顾性评估胸部CT,通过聚类分析识别出三个间质性肺病亚组:实变型(与抗MDA5抗体阳性相关)、网状型(无囊肿、实变少)和囊肿型(均伴抗PL12抗体)。观察者内分类一致性良好至优秀(Cohen κ 0.64-0.81),观察者间信度良好(Fleiss κ 0.56)。
要点
- CT上囊肿、实变和网状模式可区分三个间质性肺病亚组,并与肌炎特异性自身抗体相关。
- 实变型组抗MDA5抗体阳性率显著更高(p < 0.05)。
- 囊肿型组全部患者均伴抗PL12抗体。
核心结论
- 尽管特发性炎性肌病存在异质性,CT标准可将间质性肺病分为三个与肌炎特异性自身抗体显著相关的聚类,放射科医师识别这些聚类有助于诊断筛查和治疗。
研究设计与样本
- 回顾性研究纳入2003—2019年所有连续特发性炎性肌病患者257例,由两名胸部放射科医师回顾性评估全部胸部CT,采用多重对应分析、层次聚类分析和分类回归树分析识别间质性肺病亚组及预测变量,另由三名独立放射科医师两次阅片按聚类分组评估重复性。
关键影像表现/征象
- 聚类1以实变为主,抗MDA5抗体阳性率显著更高(p < 0.05)。
- 聚类2患者网状模式显著更多,无囊肿且实变少。
- 聚类3患者全部有囊肿并伴抗PL12抗体。
- 聚类2和聚类3中抗合成酶综合征患者显著更多。
诊断标准与关键数值
- 257例特发性炎性肌病患者中94例(36.6%)合并间质性肺病,其中87例(93%)为肌炎特异性自身抗体阳性。
- 间质性肺病-特发性炎性肌病分布:抗合成酶综合征54例(57%)、皮肌炎21例(22%)、免疫介导坏死性肌病15例(16%)、包涵体肌炎4例(4%)。
- 将患者分入三个聚类的观察者内一致性良好至优秀(Cohen κ 0.64-0.81),观察者间信度良好(Fleiss κ 0.56)。
临床应用与阅片要点
- 放射科医师识别间质性肺病的三个CT聚类(实变型、网状型、囊肿型)有助于诊断筛查和治疗。
- 实变型聚类与抗MDA5抗体阳性相关,囊肿型聚类与抗PL12抗体相关。
- 聚类2和聚类3中抗合成酶综合征患者显著更多。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Interstitial lung disease (ILD), one of the most common extramuscular manifestations of idiopathic inflammatory myopathies (IIMs), carries a poor prognosis. Myositis-specific autoantibody (MSA)-positivity is a key finding for IIM diagnosis. We aimed to identify IIM-associated lung patterns, evaluate potential CT-ILD finding-MSA relationships, and assess intra- and interobserver reproducibility in a large IIM population.
METHODS: All consecutive IIM patients (2003-2019) were included. Two chest radiologists retrospectively assessed all chest CT scans. Multiple correspondence and hierarchical cluster analyses of CT findings identified and characterized ILD-patient subgroups. Classification and regression-tree analyses highlighted CT-scan variables predicting three patterns. Three independent radiologists read CT scans twice to assign patients according to CT-ILD-pattern clusters.
RESULTS: Among 257 IIM patients, 94 (36.6%) had ILDs; 87 (93%) of them were MSA-positive. ILD-IIM distribution was 54 (57%) ASyS, 21 (22%) DM, 15 (16%) IMNM, and 4 (4%) IBM. Cluster analysis identified three ILD-patient subgroups. Consolidation characterized cluster 1, with significantly (p < 0.05) more frequent anti-MDA5-autoantibody-positivity. Significantly more cluster-2 patients had a reticular pattern, without cysts and with few consolidations. All cluster-3 patients had cysts and anti-PL12 autoantibodies. Clusters 2 and 3 included significantly more ASyS patients. Intraobserver concordances to classify patients into those three clusters were good-to-excellent (Cohen κ 0.64-0.81), with good interobserver reliability (Fleiss's κ 0.56).
CONCLUSION: Despite the observed IIM heterogeneity, CT-scan criteria enabled ILD assignment to the three clusters, which were associated with MSAs. Radiologist identification of those clusters could facilitate diagnostic screening and therapeutics. Interstitial lung disease in patients with idiopathic inflammatory myopathy could be classified into three clusters according to CT-scan criteria, and these clusters were significantly associated with myositis-specific autoantibodies.
KEY POINTS: • Cluster analysis discerned three homogeneous groups of interstitial lung disease (ILD) for which cysts, consolidations, and reticular pattern were discriminatory, and associated with myositis-specific autoantibodies. • Like muscle- and extramuscular-specific phenotypes, myositis-specific autoantibodies are also associated with specific ILD patterns in patients with idiopathic inflammatory myopathies.
引用
- Laporte, Mariampillai, Allenbach, et al. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies. Eur Radiol. 2022. PMID: 35022809. doi:10.1007/s00330-021-08411-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。